Lv1
62 积分 2024-08-19 加入
Design, synthesis and anti-tumor activity of BTK inhibitor Orelabrutinib derivatives
13天前
已完结
Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis
16天前
已完结
Bruton tyrosine kinase inhibitors in multiple sclerosis: evidence and expectations
16天前
已完结
Next generation Bruton's tyrosine kinase inhibitors – characterization of in vitro potency and selectivity
16天前
已完结
Evobrutinib in multiple sclerosis: challenges and unmet goals
22天前
已完结
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis
22天前
已完结
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
22天前
已完结
Lead- and drug-like compounds: the rule-of-five revolution
22天前
已完结
Degradation of Bruton’s tyrosine kinase mutants by PROTACs for potential treatment of ibrutinib-resistant non-Hodgkin lymphomas
27天前
已完结
Targeting Bruton’s Tyrosine Kinase Across B-Cell Malignancies
1个月前
已完结
Metal-N4-Functionalized Graphene as Highly Active Catalysts for C–N Bond Formation in Electrochemical Urea Synthesis
皖公网安备34019202002308
